Orum Therapeutics, Inc. (KOSDAQ:475830)
13,090
-1,010 (-7.16%)
Nov 20, 2026, 3:30 PM KST
| Market Cap | 284.75B -76.2% |
| Revenue (ttm) | 40.55M -99.8% |
| Net Income | 18.51B |
| EPS | -2,754.03 |
| Shares Out | 21.75M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 72,771 |
| Open | 13,680 |
| Previous Close | 14,100 |
| Day's Range | 13,030 - 13,680 |
| 52-Week Range | 13,030 - 146,600 |
| Beta | n/a |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Mar 17, 2027 |